Approval · Notice of Compliance 7562 · 2005
SYNERCID: Notice of Compliance 7562
Issued October 28, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7562
- Date
- October 28, 2005
- Company
- Monarch Pharmaceuticals Ireland LimitedDublin, --, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNERCID | 02241323 | Cancelled Post Market |
Medicinal ingredients
- QUINUPRISTIN 150 MG per VIAL
- DALFOPRISTIN 350 MG per VIAL